Clinical Trial Update: Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 neoadjuvant trial evaluating accelerated short-course photon radiotherapy with capecitabine for resectable pancreatic cancer; the trial was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-07-14